I/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.An actualiMSCupdateI won't diluteshareholdersWe will openupinternationalsites forMino-Lok trialWe haveenough cashto go wellinto 2023I/ONTAK'spotentialmarket is>$300mMino-Lokpotentialmarket>$1BMyron Holubiakand I founded aprivatecompany in2013Insidersinvested$26.5mMino-WrapI/ONTAKwas thebest deal Iever madeI'm ashareholdermyselfOnly biotechwith 2 Myron'son theleadershipteamThe name Citiuscomes from theOlympic motto"Citius,AltiusFortius"We intendto submita BLA in2H 2022We willhaveexclusivityThere are noFDAapproveddrugs to treathemorrhoidsWe had aphase 2btrial with100%efficacyNot manycompaniesthis size with2 late stageassetsI/ONTAKis our leadassetOur Halo-Lido trial willhave finalpatient byend of 2022Mino-Lokis our leadassetHemorrhoidsis a $2BmarketWe expect tofinish theMino-Loktrial this yearI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.An actualiMSCupdateI won't diluteshareholdersWe will openupinternationalsites forMino-Lok trialWe haveenough cashto go wellinto 2023I/ONTAK'spotentialmarket is>$300mMino-Lokpotentialmarket>$1BMyron Holubiakand I founded aprivatecompany in2013Insidersinvested$26.5mMino-WrapI/ONTAKwas thebest deal Iever madeI'm ashareholdermyselfOnly biotechwith 2 Myron'son theleadershipteamThe name Citiuscomes from theOlympic motto"Citius,AltiusFortius"We intendto submita BLA in2H 2022We willhaveexclusivityThere are noFDAapproveddrugs to treathemorrhoidsWe had aphase 2btrial with100%efficacyNot manycompaniesthis size with2 late stageassetsI/ONTAKis our leadassetOur Halo-Lido trial willhave finalpatient byend of 2022Mino-Lokis our leadassetHemorrhoidsis a $2BmarketWe expect tofinish theMino-Loktrial this year

Leonard Mazur HCW Conference - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  2. An actual iMSC update
  3. I won't dilute shareholders
  4. We will open up international sites for Mino-Lok trial
  5. We have enough cash to go well into 2023
  6. I/ONTAK's potential market is >$300m
  7. Mino-Lok potential market >$1B
  8. Myron Holubiak and I founded a private company in 2013
  9. Insiders invested $26.5m
  10. Mino-Wrap
  11. I/ONTAK was the best deal I ever made
  12. I'm a shareholder myself
  13. Only biotech with 2 Myron's on the leadership team
  14. The name Citius comes from the Olympic motto "Citius,Altius Fortius"
  15. We intend to submit a BLA in 2H 2022
  16. We will have exclusivity
  17. There are no FDA approved drugs to treat hemorrhoids
  18. We had a phase 2b trial with 100% efficacy
  19. Not many companies this size with 2 late stage assets
  20. I/ONTAK is our lead asset
  21. Our Halo-Lido trial will have final patient by end of 2022
  22. Mino-Lok is our lead asset
  23. Hemorrhoids is a $2B market
  24. We expect to finish the Mino-Lok trial this year